Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
2.990
+0.040 (1.36%)
Dec 20, 2024, 4:00 PM EST - Market closed
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $107.32 million as of December 20, 2024. Its market cap has decreased by -6.93% in one year.
Market Cap
107.32M
Enterprise Value
97.82M
1-Year Change
-6.93%
Ranking
Category
Stock Price
2.99
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $107.32M, an increase of 74.17%. That is a compound annual growth rate of 15.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 107.32M | -3.19% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lineage Cell Therapeutics | 110.65M |
| Editas Medicine | 110.61M |
| TELA Bio | 110.29M |
| Cassava Sciences | 110.17M |
| TriSalus Life Sciences | 109.78M |
| Acumen Pharmaceuticals | 108.14M |
| MultiPlan | 107.86M |
| Cardiol Therapeutics | 107.44M |